13F HOLDINGS REPORT
Rosalind Advisors, Inc.
Quarter ended Q2 2024 · Filed July 12, 2024 · Accession 0001622627-24-000045
Total Value
$130.0M
Positions
40
Other Managers
0
Confidential Omitted
No
Holdings (40)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | DELCATH SYSTEMS, INC. | DCTH | 2,650,389 | $15.5M | 11.95% |
| 2 | MYOMO INC | MYO | 2,664,999 | $8.6M | 6.58% |
| 3 | MEDIWOUND LTD | MDWD | 513,490 | $8.0M | 6.13% |
| 4 | OPTINOSE INC | 68404V100 | 7,547,148 | $7.8M | 6.04% |
| 5 | ABEONA THERAPEUTICS-NEW | ABEO | 1,750,000 | $7.4M | 5.71% |
| 6 | XERIS BIOPHARMA HLDGS INC | XERS | 3,120,170 | $7.0M | 5.40% |
| 7 | CELLECTAR BIOSCIENCES INC | CLRB | 2,705,616 | $6.8M | 5.20% |
| 8 | INSPIREMD INC | NSPR | 2,513,641 | $6.3M | 4.83% |
| 9 | CYBIN INC | HELP | 19,300,000 | $5.2M | 4.02% |
| 10 | Ocular Therapeutix, Inc | OCUL | 750,000 | $5.1M | 3.95% |
| 11 | ABIVAX SA | AAVXF | 378,416 | $5.0M | 3.85% |
| 12 | PROFOUND MEDICAL CORP | PROF | 533,333 | $4.5M | 3.44% |
| 13 | COMPASS PATHWAYS PLC | CMPS | 734,000 | $4.4M | 3.41% |
| 14 | TREVI THERAPEUTICS INC | TRVI | 1,391,577 | $4.1M | 3.19% |
| 15 | KALVISTA PHARMACEUTICALS INC | KALV | 337,985 | $4.0M | 3.06% |
| 16 | VIRIDIAN THERAPEUTICS INC | VRDN | 300,000 | $3.9M | 3.00% |
| 17 | VERONA PHARMA PLC | 925050106 | 250,000 | $3.6M | 2.78% |
| 18 | CLEARSIDE BIOMEDICAL INC | CLSDQ | 2,592,593 | $3.4M | 2.59% |
| 19 | OUTLOOK THERAPEUTICS INC | OTLK | 450,000 | $3.3M | 2.56% |
| 20 | VERU INC | VERU | 2,696,003 | $2.3M | 1.75% |
| 21 | POLYPID LTD | PYPD | 416,800 | $1.8M | 1.38% |
| 22 | CASSAVA SCIENCES INC | 14817C957 | 3,673 | $1.3M | 1.00% |
| 23 | REZOLUTE INC | RZLT | 250,000 | $1.1M | 0.83% |
| 24 | KIORA PHARMACEUTICALS INC | KPHMW | 255,555 | $1.1M | 0.83% |
| 25 | SPDR SER TR | 78464A870 | 22,403 | $1.0M | 0.80% |
| 26 | FORTRESS BIOTECH INC-NEW | FBIOP | 607,797 | $1.0M | 0.80% |
| 27 | GERON CORP | GERN | 200,000 | $848,000 | 0.65% |
| 28 | ANNOVIS BIO INC | ANVS | 24,154 | $839,175 | 0.65% |
| 29 | UNICYCIVE THERAPEUTICS INC | UNCY | 1,571,200 | $787,328 | 0.61% |
| 30 | SPRUCE BIOSCIENCES INC | SPRB | 1,508,419 | $780,908 | 0.60% |
| 31 | TALPHERA INC | TLPH | 758,966 | $675,480 | 0.52% |
| 32 | JOURNEY MEDICAL CORP | DERM | 114,132 | $643,704 | 0.50% |
| 33 | BEYOND AIR INC | XAIR | 903,614 | $485,511 | 0.37% |
| 34 | BIOFRONTERA INC | BFRIW | 504,261 | $452,826 | 0.35% |
| 35 | G1 THERAPEUTICS INC | 3621LQ959 | 19,018 | $304,815 | 0.23% |
| 36 | LYRA THERAPEUTICS INC | LYRA | 1,034,773 | $286,321 | 0.22% |
| 37 | NEWAMSTERDAM PHARMA CO NV | NAMSW | 10,123 | $194,463 | 0.15% |
| 38 | BIOXCEL THERAPEUTICS INC | BTAI | 39,672 | $50,780 | 0.04% |
| 39 | TONIX PHARMA HLDG CRP | TNXP | 28,154 | $19,635 | 0.02% |
| 40 | ALNYLAM PHARMACEUTICALS INC | ALNY | 700 | $0 | 0.00% |